Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Carefirst Caremark / Xalkori Crizotinib

Xalkori Crizotinib — Carefirst Caremark

5 indications indexed for this drug.

Anaplastic Large Cell Lymphoma Alcl
View coverage criteria
Cutaneous Melanoma
View coverage criteria
Histiocytic Neoplasms Erdheim Chester Disease Rosai Dorfman
View coverage criteria
Inflammatory Myofibroblastic Tumor Imt
View coverage criteria
Non Small Cell Lung Cancer Nsclc
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.